ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022: An AI-Derived Digital Pathology-Based Biomarker to Predict the Benefit of ADT in Localized Prostate Cancer With Validation in NRG/RTOG 9408
By
ASCO Genitourinary Cancers Symposium
FEATURING
Daniel Spratt
By
ASCO Genitourinary Cancers Symposium
FEATURING
Daniel Spratt
43 views
March 14, 2022
Comments 0
Login to view comments.
Click here to Login
Videos